Acutus Medical Inc.

0.04
-0.01 (-14.89%)
At close: Mar 27, 2025, 10:59 AM

Acutus Medical Statistics

Share Statistics

Acutus Medical has 29.91M shares outstanding. The number of shares has increased by 1.62% in one year.

Shares Outstanding 29.91M
Shares Change (YoY) 1.62%
Shares Change (QoQ) 0.19%
Owned by Institutions (%) 0.01%
Shares Floating 24.31M
Failed to Deliver (FTD) Shares 1.76K
FTD / Avg. Volume 4.44%

Short Selling Information

The latest short interest is 553.6K, so 1.86% of the outstanding shares have been sold short.

Short Interest 553.6K
Short % of Shares Out 1.86%
Short % of Float 2.04%
Short Ratio (days to cover) 0.68

Valuation Ratios

The PE ratio is -0.17 and the forward PE ratio is -0.03. Acutus Medical's PEG ratio is 0.

PE Ratio -0.17
Forward PE -0.03
PS Ratio 0.08
Forward PS 0
PB Ratio -0.14
P/FCF Ratio -0.05
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Acutus Medical Inc. has an Enterprise Value (EV) of 18.15M.

EV / Earnings -1.9
EV / Sales 0.9
EV / EBITDA 8.07
EV / EBIT -318.48
EV / FCF -0.57

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of -3.09.

Current Ratio 2.06
Quick Ratio 1.91
Debt / Equity -3.09
Total Debt / Capitalization 147.96
Cash Flow / Debt -0.89
Interest Coverage -0.01

Financial Efficiency

Return on equity (ROE) is 0.82% and return on capital (ROIC) is -0.24%.

Return on Equity (ROE) 0.82%
Return on Assets (ROA) -0.33%
Return on Capital (ROIC) -0.24%
Revenue Per Employee $237,141.18
Profits Per Employee $-112,317.65
Employee Count 85
Asset Turnover 0.7
Inventory Turnover 10.69

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -73.4% in the last 52 weeks. The beta is -0.13, so Acutus Medical's price volatility has been lower than the market average.

Beta -0.13
52-Week Price Change -73.4%
50-Day Moving Average 0.05
200-Day Moving Average 0.06
Relative Strength Index (RSI) 46.09
Average Volume (20 Days) 39.76K

Income Statement

In the last 12 months, Acutus Medical had revenue of 20.16M and earned -9.55M in profits. Earnings per share was -0.32.

Revenue 20.16M
Gross Profit 1.01M
Operating Income -57K
Net Income -9.55M
EBITDA 2.25M
EBIT -57K
Earnings Per Share (EPS) -0.32
Full Income Statement

Balance Sheet

The company has 14.02M in cash and 35.76M in debt, giving a net cash position of -21.75M.

Cash & Cash Equivalents 14.02M
Total Debt 35.76M
Net Cash -21.75M
Retained Earnings -609.52M
Total Assets 28.65M
Working Capital 13.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.66M and capital expenditures -112K, giving a free cash flow of -31.77M.

Operating Cash Flow -31.66M
Capital Expenditures -112K
Free Cash Flow -31.77M
FCF Per Share -1.07
Full Cash Flow Statement

Margins

Gross margin is 5.03%, with operating and profit margins of -0.28% and -47.36%.

Gross Margin 5.03%
Operating Margin -0.28%
Pretax Margin -22.5%
Profit Margin -47.36%
EBITDA Margin 11.16%
EBIT Margin -0.28%
FCF Margin -157.62%

Dividends & Yields

AFIB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -640%
FCF Yield -2042.64%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for AFIB.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -28.37
Piotroski F-Score 3